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CD4 down-regulationThe Vpu protein of human immunodeﬁciency virus type 1 (HIV-1) is known to enhance virion release from
certain cell types. To accomplish this function, Vpu interacts with the restriction factor known as bone
marrow stromal cell antigen 2 (BST-2)/tetherin. In this study, we analyzed whether the Vpu protein is
associated with microdomains known as lipid or membrane rafts. Our results indicate that Vpu partially
partitions into detergent-resistant membrane (DRM) fractions when expressed alone or in the context of
simian–human immunodeﬁciency virus (SHIV) infection. The ability to be partitioned into rafts was
observed with both subtype B and C Vpu proteins. The use of cholesterol lowering lovastatin/M-β-
cyclodextrin and co-patching experiments conﬁrmed that Vpu can be detected in cholesterol rich regions of
membranes. Finally, we present data showing that raft association-defective transmembrane mutants of Vpu
have impaired enhanced virus release function, but still maintain the ability to down-regulate CD4.gy, Molecular Genetics, and
1 Rainbow Blvd., Kansas City,
.
lsevier Inc.© 2010 Published by Elsevier Inc.Introduction
Viral protein U (Vpu) encoded by human immunodeﬁciency virus
type I (HIV-1) augments viral pathogenesis by down-modulating CD4
molecules from the surface of infected cells and enhancing virion
release (Fujita et al., 1997; Klimkait et al., 1990; reviewed in Ruiz et al.,
2010; Schubert et al., 1998; Strebel et al., 1988). Membrane
association is critical for both activities although an earlier study
indicated that the primary structure of the transmembrane domain
was irrelevant for CD4 down-modulation (Schubert et al., 1996). The
ability of Vpu to enhance virion release from some cell types has been
attributed to antagonism of the cellular protein bone marrow stromal
antigen 2 (BST-2; also known as CD317, HM1.24 and tetherin) (Neil et
al., 2008; Van Damme et al., 2008). BST-2 localizes to the sites of HIV-1
budding and provides a physical, protease-sensitive link between the
cellular and viral membranes (Perez-Caballero et al., 2009). BST-2 is a
type II integral membrane protein that is anchored into the cell
membrane by an amino terminal transmembrane domain and by a
glycophosphatidylinositol (GPI) anchor at the carboxyl terminal
region. GPI-anchored proteins are often found in membrane micro-
domains known as membrane rafts and fully processed BST-2 has
been shown to partition to these domains (Kupzig et al., 2003). Amore recent study documented a punctate distribution of BST-2 on
the surface of HIV-1 infected cells and that removal of the GPI anchor
resulted in BST-2 being exclusively associated with sites of assembly
suggesting that BST-2 may partition to multiple types of micro-
domains with distinct membrane compositions (Perez-Caballero
et al., 2009). As it is documented that the subtype B Vpu is neither
incorporated into virions nor is it present at the sites of HIV-1
assembly and maturation, the location of Vpu-mediated antagonism
of BST-2 has remained in question. However, since BST-2 may
partition to multiple, compositionally distinct rafts during intracellu-
lar processing, it may interact with Vpu in rafts distinct from those
essential to HIV-1maturation and egress. Themechanism(s) bywhich
Vpu counteracts BST-2 are under investigation but the down-
regulation of BST-2 from the cellular surface, increased degradation
of BST-2 and sequestration at alternate intracellular sites are all
potentially dependent on co-partitioning to similar membrane rafts.
Membrane rafts are essential to HIV-1 replication as the assembly
and budding of virions is a dynamic process that is dependent upon
the association of viral proteins with these microdomains (Ono and
Freed, 2001). HIV-1 proteins Gag, Env and Nef have been identiﬁed as
membrane raft associated proteins and the partitioning to these
microdomains is essential for assembly, budding and enhancement of
viral infectivity (Nguyen and Hildreth, 2000). Membrane rafts are
enriched in cholesterol and sphingolipids forming tightly packed,
highly ordered regions within the membrane. The presence of
cholesterol and sphingolipids in rafts confers resistance to solubiliza-
tion by some non-ionic detergents such as Triton X-100 at low
temperatures. Due to their insolubility, membrane rafts are often
90 A. Ruiz et al. / Virology 408 (2010) 89–102referred to as detergent-resistant membranes (DRMs). Because the
isolation of DRMs is accomplished at 4 °C and isolated DRMs are 0.1 to
1 μm vesicles, some investigators have questioned their existence in
live cells. However, more recent studies have shown that DRMs can
also be isolated by extraction at physiological temperature (Chen
et al., 2009). Additionally, morphological approaches (confocal
microscopy; atomic force microscopy, and ﬂuorescence resonance
energy transfer) have been used to study in situ localization of
membrane rafts (Pralle et al., 2000; Prior et al., 2003; Sharma et al.,
2004; Kusumi and Suzuki, 2005).
In this study, we employed both biochemical and morphological
approaches to determine whether Vpu associates with membrane
rafts and further characterized the potential for this association to
affect both functions of Vpu. We report here that Vpu partially
partitions to detergent-resistant membrane microdomains in a
cholesterol dependent manner. We also demonstrate the involve-
ment of the transmembrane domain in this partitioning and identify
targeted mutations within this domain that abolish membrane raft
association. Furthermore, membrane raft association of the Vpu
protein correlates with the enhancement of virion release function,
but not CD4 surface down-regulation. Taken together, these results
establish that separate Vpu functions require distinct membrane
localization patterns, implicate speciﬁc regions of the transmem-
brane domain as targets for disrupting Vpu function and provide
further evidence for the importance of membrane rafts in HIV-1
pathogenesis.
Results
The subtype B Vpu protein partially partitions to the detergent-resistant
membrane fractions
We transfected 293 cells with a vector expressing a codon-
optimized version of the subtype B Vpu (Vphu) and at 48 h the DRMs
were isolated on sucrose gradients using ultracentrifugation. Frac-
tions were collected from the top of the gradients, the proteins
concentrated and analyzed by Western blot analysis. Vphu was
detected predominantly in the soluble fractions at the bottom of the
gradient (Fig. 1; upper panel) where a non-raft protein (transferrin
receptor) was located (Fig. 1; lower panel). However, the Vphu
protein was also detected at fractions at the top of the gradient that
corresponded to the DRMs. The DRM fractions were identiﬁed by the
presence of ﬂotillin 1 (a raft protein) (Fig. 1; middle panel). All
experiments were performed at least twice, and at most three times.
Blots shown are representative of all experiments. The results provide
evidence that Vpu is partially partitioned into membrane raft
proteins.Fig. 1. Vpu partitions into detergent-resistant membrane (DRM) fractions. 293 cells
were transfected with a plasmid expressing Vphu protein. At 48 h, cells were lysed in
ice cold DRM buffer containing 1% Triton X-100, and raft proteins separated from non-
raft proteins on discontinuous sucrose gradients by ultracentrifugation as described in
the Materials and methods section. Fractions were collected from the top of the
gradient, and Vpu proteins detected by Western blot analysis using a rabbit anti-Vpu
serum (upper panel) or stripped and reprobed with either an antibody directed against
raft protein ﬂotillin-1 (middle panel) or the non-raft protein transferrin receptor
(lower panel). Fraction 1 is the top of the gradient and fraction 12 the bottom of the
gradient.Vpu is detected in the DRM fractions isolated from virus-infected cells
We next determined if the Vpu could be detected in DRM fractions
from virus-infected cells. C8166 cells were inoculated with 104 TCID50
of simian–human immunodeﬁciency virus expressing an intact Vpu
protein (SHIVKU-1bMC33) or no Vpu protein (novpuSHIVKU-1bMC33) and
incubated for 5 days. At 5 days, cells were starved and radiolabeled
with 35S-methionine/cysteine for 2 h followed by DRM extraction and
isolation by ultracentrifugation. Fractions containing the DRMs
(fractions 1–3; I), the middle of the gradient (fractions 6–7; M), and
the soluble non-raft proteins (fractions 10–12; S) were each pooled,
the Vpu proteins were immunoprecipitated using a rabbit anti-Vpu
antibody, and the proteins separated by SDS-PAGE. Aliquots were
analyzed by Western blot for ﬂotillin-1 or transferrin receptor. Vpu
could be detected in both the DRM (top of gradient) and soluble
fractions, but very little was detected in fractions collected from the
middle of the gradient (Fig. 2). All experiments were performed at
least twice, and at most three times. These results indicate that Vpu
could also be detected in DRMs isolated from virus-infected T cells.
Vpu fusion proteins also partition to DRMs
To facilitate the detection of Vpu in different compartments of the
cell, we previously developed a vector that expressed Vpu fused to the
protein enhanced green ﬂuorescent protein (VpuEGFP) (Singh et al.,
2003; Pacyniak et al., 2005). We determined if the VpuEGFP protein
would also partition to the DRM fractions. Cells were transfected with
vectors expressing either the subtype B fusion protein (VpuEGFP) or
the subtype C Vpu protein (VpuSCEGFP1) and fractionated as
described above. Both the VpuEGFP and VpuSCEGFP1 were detected
in the DRM fractions, indicating that these tagged proteins could be
used to study raft association (Figs. 3A–B). All experiments were
performed at least twice, and at most three times.
Cholesterol depletion abolishes the ability of VpuEGFP and VpuSCEGFP1
to be partitioned to the DRM fractions
As membrane rafts are rich in cholesterol, compounds that reduce
cholesterol levels in cells such as M-β-cyclodextrin (M-β-CD) or
statins disrupt membrane raft formation (Keller and Simons, 1998;
Scheiffele et al., 1999). We examined if lovastatin/M-β-CD treatment
would reduce the level of Vpu in DRM fractions. 293 cells were
transfected with vectors expressing VpuEGFP or VpuSCEGFP1, treatedFig. 2. Vpu expressed in virus-infected cells also partitions into DRM fractions. C8166
cells were inoculated with 100 ng of SHIVKU-1bMC33 or novpuSHIVKU-1bMC33 and
incubated for 5 days. At this time cells were starved for methionine/cysteine for 2 h
and radiolabeled for 2 h with 1 mCi of 35S-methionine/cysteine. The cells were
harvested by low speed centrifugation, washed, and lysed in ice cold DRM buffer
containing 1% Triton X-100. Raft proteins were separated from non-raft proteins using
discontinuous sucrose gradients by ultracentrifugation as described in the Materials
and methods section. Fractions 1–3, 6–7 and 10–12 were pooled and the Vpu proteins
immunoprecipitated using a rabbit anti-Vpu serum and immunoprecipitates collected
on Protein A-Sepharose beads. The remaining supernatants were analyzed by Western
blot for ﬂotillin-1 and transferrin receptor. The proteins were separated using SDS-
PAGE and proteins visualized using standard autoradiographic techniques.
Fig. 3. Vpu fusion proteins also partition into detergent-resistant membranes and cholesterol depletion reduces the amount of VpuEGFP and VpuSCEGFP1 in DRM fractions. Left side
of panels A and B. 293 cells were transfected with vectors expressing either VpuEGFP (panel A) or VpuSCEGFP1 (panel B) proteins. At 48 h, cells were lysed in ice cold DRM buffer
containing 1% Triton X-100, and raft proteins separated from non-raft proteins on discontinuous sucrose gradients by ultracentrifugation as described in the Materials and methods
section. Fractions 1–3 (I), fractions 6–7 (M) and 10–12 (S) were pooled, concentrated and the Vpu proteins detected by Western blot analysis using a rabbit anti-EGFP serum. Right
side of panels A and B. 293 cells were transfected with vectors expressing either VpuEGFP (panel A) or VpuSCEGFP1 (panel B) proteins. Following transfection, cells were incubated in
the presence of 4 μM lovastatin for 48 h. Thirty minutes prior to lysis, M-β-CD was added to a ﬁnal concentration of 10 mg/ml. Cells were processed as described for the untreated
samples. Panels C–D. Micrographs of untreated cultures (panel C) or those treated with M-β-CD (panel D).
Fig. 4. Vpu partitions into membrane rafts isolated at physiological temperature. 293
cells were transfected with a vector expressing VpuEGFP and incubated at 37 °C. At 48 h
post-transfection, cells solubilized in DRM37 buffer with 1% Triton X-100 and raft
proteins separated from non-raft proteins using discontinuous ﬂotation sucrose
gradients and ultracentrifugation as described in the Materials and methods section.
Fractions were collected and VpuEGFP, ﬂotillin or transferrin receptor detected by
Western blot analysis using antibodies described in theMaterials andmethods. Panel A.
Detection of VpuEGFP. Panel B. Detection of ﬂotillin-1. Panel C. Detection of transferrin
receptor. Fraction 1 is the top of the gradient and fraction 9 the bottom of the gradient.
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prior to cell lysis. The cells were lysed as described above, DRM and
soluble fractions separated by ultracentrifugation and fractions
collected as described above. All experiments were performed at
least twice, and at most three times. The results clearly indicate that
there were reduced levels of Vpu B and C fusion proteins in the
DRM fractions following treatment with lovastatin and M-β-CD,
indicating that Vpu resistance to Triton X-100 is cholesterol
dependent and likely correlates with raft association (Figs. 3A–B).
The observation of ﬂotillin-1 in rafts of lovastatin/M-β-CD treated
cells may relate to the ability of ﬂotillin-1 to occupy detergent-
resistant, buoyant complexes that do not rely on cholesterol for their
integrity and has been previously reported (Browman et al., 2006;
Gkantiragas et al., 2001). Companion monolayers of 293 cells treated
with lovastatin and M-β-CD showed no toxicity/cell death compared
to untreated cells using microscopy (Figs. 3C–D) and trypan blue
staining (data not shown).
Vpu partially partitions into membrane rafts isolated at
physiological temperature
Classical methods of the isolation of DRMs involve solubilization at
4 °C, which has been challenged by some investigators. Therefore, we
also examined Vpu partitioning into membrane raft fractions when
the extraction was performed at 37 °C. 293 cells were transfected
and at 48 h post-transfection, were lysed in DRM37 buffer plus 1%
Triton X-100 and rafts isolated as described in the Materials and
methods section (Chen et al., 2009). Rafts were separated from non-
rafts by ultracentrifugation and fractions collected. The fractions were
analyzed by Western blotting for the presence of Vpu, ﬂotillin, andtransferrin receptor. The raft (ﬂotillin 1) and non-raft (transferrin
receptor) markers were predominantly localized at the top and
bottomof the gradients, respectively (Fig. 4). Vpuwas detected in both
raft and non-raft fractions, similar to what we observed with
solubilization of cells in the presence of 1% Triton X-100 at 4 °C. All
experiments were performed at least twice, and at most three times.
These results show the Vpu could be detected in DRMs at physiological
temperature.
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raft protein
To further verify that Vpu is found in membrane rafts, we
employed co-patching techniques for aggregating membrane rafts
to a size visible by confocal microscopy and then examined ifFig. 5. Co-patching experiments reveal that VpuSCEGFP1 partially co-localizes with NFP-GPI.
E, H, K, and N are ﬂuorescent micrographs for Cy5. Panels C, F, I, L, and O are a merge of the
vector expressing VpuSCEGFP1. Note the punctuate ﬂuorescence in panel C. Panels D–F. 293
cells were transfected with a vector expressing YFP-GPI and co-patched. Panels J–O. 293 ceVpuSCEGFP1 co-localized with a known membrane raft protein. We
used plasmids expressing either a ﬂuorescent or non-ﬂuorescent form
of YFP with an ER translocation signal and a GPI anchor sequence. This
protein is recognized by a mouse anti-GFP antibody (Clontech) in live
cells, as the YFP portion of the protein is found extracellularly. While
all known Vpu proteins are found in small amounts at the cell surface,Panels A, D, G, J, and M are ﬂuorescent micrographs using a ﬁlter for YFP/EGFP. Panels B,
two ﬂuorescent micrographs to the left. Panels A–C. 293 cells were transfected with a
cells were transfected with a vector expressing YFP-GPI and pre-ﬁxed. Panels G–I. 293
lls were transfected with both VpuSCEGFP1 and NFP-GPI.
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visualization of raft association difﬁcult in live cells. Most live cell
methods of raft detection involve surface staining or aggregation of
rafts by cholera toxin or antibody co-patching. To increase the
likelihood of ﬁnding Vpu in a raft by these methods, we utilized a Vpu
protein which is predominantly found at the cell surface, VpuSC
(Pacyniak et al., 2005). We used several controls to validate this
approach. First, cells were transfected with the plasmid expressing
VpuSCEGFP1 and live stained with anti-GFP as described in the
Materials and methods (Figs. 5A–C). As expected, these cells show no
staining, since the EGFP tag of VpuSCEGFP1 is cytoplasmic. We next
transfected cells with the plasmid expressing YFP-GPI, ﬁxed and then
stained with mouse anti-GFP (Figs. 5D–F). The antibody staining
shows nearly complete co-localization at the cell surface, indicative of
antibody speciﬁcity to the extracellular YFP. Finally, we transfected
cells with the plasmid expressing YFP-GPI, then stained the live cells
at 37 °C as described in Materials and methods (Figs. 5G–I). This
induces aggregation of the membrane rafts, making them visible by
standard microscopy. Note the punctate staining of the co-patched
YFP-GPI compared to the pre-ﬁxed sample. To determine if Vpu-
SCEGFP1would co-localize with this membrane raft protein, we used a
plasmid expressing a non-ﬂuorescent version of the same YFP-GPI
construct (NFP-GPI), which produces no background (data not
shown). This allowed us to use the VpuSCEGFP1 protein without
having overlapping ﬂuorescent signals. Cells were co-transfected with
plasmids expressing NFP-GPI and VpuSCEGFP1, then stained at 37 °C
(Figs. 5J–O). VpuSCEGFP1 partially co-localized with the patches of
NFP-GPI, indicating that Vpu is found in at least some GPI-anchored
protein containing membrane rafts. This provides additional evidence
that Vpu is a membrane raft protein.The transmembrane domain of Vpu is involved in raft association
We next determined if amino acids within the transmembrane
domain were involved in the transport of VpuEGFP to membrane
rafts. Previous studies have shown that scrambling the hydrophobic
amino acids of the transmembrane domain (VpuTMEGFP) results in a
protein that is transported to similar compartments within the cell
but unable to enhance virus release or down-regulate CD4 expression
from the cell surface (Schubert et al., 1996; Hout et al., 2005). We
determined if this Vpu fused to EGFP (VpuTMEGFP) would partition to
raft fractions. The results shown in Fig. 6 indicate that VpuTMEGFP
partitioned exclusively to the detergent soluble fractions of the
gradient. All experiments were performed at least twice, and at most
three times. Blots shown are representative of all experiments.
Appropriate controls for raft isolation and purity were performedFig. 6. Scrambling the transmembrane domain prevents VpuEGFP raft association. 293 cell
48 h, cells were lysed in ice cold DRM buffer containing 1% Triton X-100, and raft proteins sep
as described in the Materials and methods section. Fractions were collected from the top of t
were analyzed for the presence of Vpu, Flotillin-1 and transferrin receptor proteins by Wesand are shown. These results provide genetic evidence for the
speciﬁcity of Vpu partitioning to the DRM fractions.
Characterization of Vpu transmembrane mutants
Based on the above results suggesting the involvement of the
transmembrane domain in raft association, we constructed a series of
vectors expressing Vphu proteins with 1–3 amino acid changes in the
transmembrane domain (Fig. 7A). We ﬁrst analyzed the stability of
these mutants using pulse–chase analysis. 293 cells were transfected
with each mutant or the unmodiﬁed Vphu. At 48 h, the cells were
starved and radiolabeled with 35S-methionine/cysteine and then the
radiolabel chased in cold excess methionine/cysteine for 0 and 6 h. All
conditions were run in duplicate and the average percent protein
remaining and standard deviation calculated. The results indicate that
the majority of the Vphu mutants had a similar stability or were more
stable than the unmodiﬁed Vphu, which had 47% remaining at the 6-
hour chase period (Figs. 7B–C). Vphu mutants W22A and SI23,24AA
had less protein remaining at the 6-hour chase period (28% and 38%,
respectively).
Identiﬁcation of critical amino acids in the transmembrane domain of
Vpu that are required for membrane raft association
We determined if one or more amino acid residues within the
transmembrane domain were critical for membrane raft association.
Vectors expressing these mutant Vphu proteins were transfected into
293 cells and at 36 h the DRMs were isolated as described above. All
experiments were performed at least twice, and at most three times.
Blots shown are representative of all experiments. Appropriate
controls for raft isolation and purity were performed and are
shown. We found that two mutants, W22A and IVV19-21AAA had
no detectable Vpu in the DRM fractions (Fig. 8A). Additionally,
substitution of the W22 with the more hydrophobic leucine did not
affect raft association (Fig. 8B). Taken together, these results suggest
that membrane raft association can be manipulated by substituting
speciﬁc amino acids in the TM domain.
The W22A mutant is localized to the same compartments as the
unmodiﬁed VpuEGFP
As the W22A mutant appeared to have the greatest effect on raft
association, we determined if this mutant was mislocalized in the cell.
293 cells were transfected with vectors expressing either VpuEGFP or
VpuEGFPW23A and ER, Golgi or membrane markers. The results
indicate that the VpuEGFP (Figs. 9A–I) and the VpuEGFPW23A
(Figs. 9J–R) were localized to similar compartments, suggesting thats were transfected with vectors expressing either VpuEGFP or VpuTMEGFP proteins. At
arated from non-raft proteins on discontinuous sucrose gradients by ultracentrifugation
he gradient, and fractions from the top (1–3; I) middle (6–7; M) and bottom (10–12; S)
tern blot analysis using antibodies described in the Materials and methods.
Fig. 7. Vphu transmembrane mutants exhibit limited changes in protein stability. Panel A. A series of transmembrane mutants were constructed in which 1–3 non-alanine residues
were changed to alanines. Panel B. Pulse–chase analysis of the Vphu transmembrane mutants. 293 cells were transfected with either the unmodiﬁed Vphu or the Vphu TMmutants.
At 48 h, cells were starved for methionine/cysteine and radiolabeled for 1 h as described in the Materials and methods section. The radiolabel was removed, cells washed and
incubated in excess cold methionine/cysteine for 0 and 6 h. The cells were lysed and processed for immunoprecipitation assays using a rabbit anti-Vpu serum. The
immunoprecipitates were collected on Protein A-Sepharose, boiled and visualized by SDS-PAGE (12% gel) and standard autoradiographic techniques. The numbers above each lane
represent the length of time chased in cold medium.
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lack of raft association by the W22A/W23A mutants.
Membrane raft association correlates with enhanced virus release
We examined these same mutants for the ability to enhance virus
release from infected cells. For these experiments, we used HeLa cells,
which express bone marrow stromal antigen 2 (BST-2). Vpu has beenshown to interact with BST-2 to permit enhanced virus release from
infected cells (Douglas et al., 2009). HeLa cells were co-transfected
with plasmids expressing the Vphu mutants described above and
SHIVΔVpu and assessed for p27 release. All conditions were run at
least four separate times and the average percent p27 release and
standard error calculated. The results indicate that Vpu mutants
W22A and IVV19-21AAA and to a lesser extent LVV11-13AAA showed
a signiﬁcant decrease in p27 release, which correlated well with the
Fig. 8. Identiﬁcation of Vphu transmembrane mutants that are not associated with membrane rafts. 293 cells were transfected with vectors expressing each of the raft mutants
described in Fig. 7A. At 48 h, DRMswere extracted and isolated as described in the Materials and methods section. Fractions 1–3 (rafts; I), 5–6 (middle of the gradient; M) and 10–12
(non-raft; S) were pooled and analyzed for the presence of Vpu, ﬂotillin-1, and transferrin receptor. Panel A. 293 cells transfected with vectors expressing each of the Vphu mutants
described in Fig. 7A. Panel B. 293 cells transfected with vectors expressing VpuEGFPW23A and VpuEGFPW23L mutants described in Fig. 7A.
95A. Ruiz et al. / Virology 408 (2010) 89–102lack of association with membrane rafts (Fig. 10A). Analysis of
infectious virus released also showed the same general pattern when
compared to the p27 assays (Fig. 10B). Signiﬁcance of the p27 and
infectious virus release for each virus mutant was assessed by
comparison to the Vphu control with a pb0.01 considered signiﬁcant.Membrane raft association is not required for CD4 down-regulation
As the other major function of Vpu is shunting of CD4 to the
proteasome for degradation, we also examined surface expression of
CD4 in the presence of these Vpu mutants. HeLa CD4+ cells were
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Fig. 10. Raft association correlates with enhanced virus release. The same mutants described in Fig. 7A were used to determine the level of virus release in the presence of human
BST-2. HeLa cells were co-transfected with SHIVΔVpu and vectors expressing Vphu or the different transmembrane mutants. At 48 h, the culture medium was collected and assayed
for p27 and infectious virus released from cells. Panel A. The level of p27 released from transfected cells. Signiﬁcance in the restriction of p27 release was calculated with respect to
the SHIVKU-2MC4 control in the presence of each respective BST-2 using a Student's t-test with pb0.01 considered signiﬁcant (★). Panel B. The level of infectious virus released as
determined by infection of TZM-bl cells and staining for the presence of β-galactosidase activity at 48 h post-inoculation as described in the Materials and methods section.
Signiﬁcance in the restriction of infectivity was determined with respect to the unmodiﬁed Vphu using a Student's t-test with pb0.01 considered signiﬁcant (★).
97A. Ruiz et al. / Virology 408 (2010) 89–102transfected with vectors expressing Vphu or the mutants described
above and EGFP. Cells were analyzed for CD4 surface expression by
ﬂow cytometry as previously described (Hill et al., 2008, 2009). All
conditions were run three separate times and the average CD4 surface
expression and standard error calculated. This Vpu function was not
impaired with the majority of these mutants (Fig. 11). The two Vphu
mutants that were not detected in rafts, Vphu-IVV19-21AAA and
W22A, had normal (VphuIVV19-21AAA) or slightly impaired (W22A)
surface CD4 down-modulation compared to the unmodiﬁed Vphu
protein. Taken together, these results indicate that raft association
was not a requirement for Vpu-mediated down-modulation of CD4.
Discussion
Many enveloped viruses such as vaccinia virus, the orthomyx-
oviruses (inﬂuenza), paramyxoviruses (measles, RSV), ﬁloviruses
(Ebola, Marburg) herpesviruses (EBV, HSV-1, pseudorabies), ﬂavi-
viruses (West Nile virus), rhabdoviruses (VSV), and retroviruses
(MLV) use membrane rafts as portals for entry and/or egress from
cells (Barman and Nayak, 2000; Bavari et al., 2002; Bender et al., 2003;
Brown and Lyles, 2003; Chung et al., 2005; Keller and Simons, 1998; Li
et al., 2002; Manié et al., 2000; Marty et al., 2004; Medigeshi et al.,
2008; Scheiffele et al., 1999). In addition to the viruses listed above,
HIV-1 also exploits membrane rafts at several steps in its replication
cycle. The HIV-1 envelope is known to be enriched in cholesterol
(Aloia et al., 1993; Brugger et al., 2005). Both Gag and Env were foundFig. 9. VpuEGFPW23A and VpuEGFP are localized to similar compartments. 293 cells were
DsRed2, Golgi-DsRed2 or Membrane-DsRed2 as described in theMaterials andmethods secti
VpuEGFP. Panels A, D, and G are ﬂuorescent micrographs showing expression of VpuEGFP. P
Panels C, F, and I are a merge of the two panels to the left. Panels A–C. 293 cells transfected w
DsRed2. Panels G–I. 293 cells transfected with VpuEGFP and Mem-DsRed2. J–R. 293 cells tra
expression of VpuEGFPW23A. Panels K, N, and Q are ﬂuorescent micrographs showing expr
Panels J–L. 293 cells transfected with VpuEGFPW23A and ER-DsRed2. Panels M–O. 293 cell
with VpuEGFPW23A and Mem-DsRed2.in detergent-resistant membranes (Nguyen and Hildreth, 2000).
These investigators found that GPI-anchored proteins such as Thy1
and CD59 as well as GM-1 ganglioside were present but that a non-
raft protein, CD45, was largely absent from viral particles. It was
subsequently shown that membrane rafts were critical for virus
assembly and release (Ono and Freed, 2001). These investigators
found that the myristylated N-terminal domain of Gag and the I
domain of the nucleocapsid protein were critical for raft association
and that the cholesterol depleting compound, M-β-CD, reduced the
efﬁciency of virus release. The palmitoylation of Env gp41was initially
shown to be important for raft targeting and infectivity but later
studies showed that substitution of the cysteines in the cytoplasmic
domain of gp41 (thus resulting in no palmitoylation) only partially
affected infectivity or had no effect (Rouso et al., 2000; Bhattacharya
et al., 2004; Chan et al., 2005). It was later shown that mutations in the
Gag p17 protein would prevent Env incorporation into rafts and
virions, suggesting that Gag regulates Env incorporation into rafts
(Bhattacharya et al., 2006; Patil et al., 2010). Other investigators have
shown that the HIV-1 Env has a cholesterol recognition/interaction
amino acid consensus (CRAC) domain that is responsible for raft
association (Epand et al. 2006; Vishwanathan et al., 2008).
In this study, we have determined that the Vpu protein partially
associates with membrane rafts. We have shown this using biochem-
ical fractionation, through the use of cholesterol reducing drugs and
co-patching experiments. In the results presented here, Vpu
expressed either exogenously in the absence of other viral proteinstransfected with vectors expressing either VpuEGFP or VpuEGFPW23A and either ER-
on. At 48 h, cells were processed for confocal microscopy. A–I. 293 cells transfected with
anels B, E, and H are ﬂuorescent micrographs showing expression of DsRed2 proteins.
ith VpuEGFP and ER-DsRed2. Panels D–F. 293 cells transfected with VpuEGFP and Golgi-
nsfected with VpuEGFPW23A. Panels J, M, and P are ﬂuorescent micrographs showing
ession of DsRed2 proteins. Panels L, O, and R are a merge of the two panels to the left.
s transfected with VpuEGFPW23A and Golgi-DsRed2. Panels P–R. 293 cells transfected
Fig. 11. CD4 down-regulation by Vphu transmembrane mutants. HeLa CD4+ cells were
transfected with plasmids expressing each of the unmodiﬁed Vphu or mutant Vphu
proteins and one expressing EGFP. At 48 h, live cells were immunostained for CD4. Cells
were assessed for CD4 surface expression using ﬂow cytometry. A mean ﬂuorescent
intensity (MFI) ratio of transfected (EGFP positive) to untransfected cells (EGFP
negative) was calculated for each sample with the EGFP transfection control
normalized to 1.0. Normalized ratios from three separate experiments were averaged
and the standard error calculated.
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studies used Triton X-100 as it is the most stringent with respect to
extraction of DRMs (Schuck et al., 2003; Shogomori and Brown, 2003).
We also showed that Vpu partially partitions into DRMs when
extracted at physiological temperature as rafts isolated at 37 °C are
thought to be more similar to rafts in live cells. In addition to showing
that Vpu partitions into DRMs, it was necessary to show that
disruption of membrane rafts by cholesterol depletion would prevent
Vpu from partitioning into DRMs. Drugs that reduce cholesterol levels
in cells, either by inhibiting an HMGCoA reductase in the cholesterol
synthesis pathway (lovastatin) or by extracting cholesterol from cell
membranes (cyclodextrin; M-β-CD), are known to disrupt membrane
rafts. We determined if a combination of lovastatin and M-β-CD
would eliminate Vpu from DRMs, which would indicate that Vpu
resistance to Triton X-100 is a speciﬁc property of raft inclusion. This
treatment signiﬁcantly reduced the level of Vpu in membrane rafts.
Finally, Vpu association with lipid rafts was conﬁrmed by co-
localization of VpuSCEGFP with a raft marker in live cells. As the
subtype B Vpu used in most of the experiments in this study is found
predominantly in the Golgi, ER, and endosomes, and only small
amounts are found at the surface, we used VpuSC, which is efﬁciently
transported to the cell surface for this assay. While it seems likely that
Vpu is associated with rafts internally, these rafts are, as yet, difﬁcult
to visualize. Most studies of rafts in Golgi bodies or endosomes have
been done using biochemical lipidomic techniques rather than live
cell imaging. Taken together, these experiments provide strong
evidence that Vpu is partially localized to membrane rafts and at
least some rafts containing GPI-anchored proteins.
As the transmembrane or membrane proximal domains are most
likely to be involved in membrane raft targeting, we examined the
detergent resistance of a Vpu fusion protein with a scrambled TM
domain (VpuTMEGFP). This protein was not associated with DRM
fractions, indicating that the TM domain may be involved in
membrane raft association. However, since this scrambled TM
domain has a total of 15 amino acid changes, it is possible that
these substitutions may have caused an alteration of the spatial
orientation of the protein in the membrane, the ﬂexible linker region
following the TM domain or the ﬁrstα-helical region proximal to the
membrane. Previousmodeling studies have indicated that changes in
the Vpu TM domain have the ability to cause secondary structure
changes downstream (Candler et al., 2005; Sramala et al., 2003). In
order to address this concern, we used Vpu mutants with more
targeted mutations. Our results indicate that Vpu mutants Vphu-
IVV19-21AAA and Vphu-W22A were no longer associated with
membrane raft fractions. While these results show that amino acid
substitutions in the TM domain can affect incorporation into rafts,
they do not necessarily rule out that other amino acids in the TMdomain (the alanine residues) or residues in the cytoplasmic domain
may also be involved. Recent computer modeling studies have
suggested that the transmembrane domain of Vpu is ﬂexible in
adapting to different lipid environments (Kruger and Fischer, 2008).
When Vpu was simulated moving through various lipid environ-
ments representative of the Golgi apparatus, Vpu exhibited no
particular preference for lipid thickness or composition. Rather, the
tilt angle and kink around the region I17 to S23 adjust to the
membrane. This modeling data correlates well with the loss of DRM
association of IVV19-21AAA and W22A. If these residues are
important to the structural ﬂexibility of the Vpu transmembrane
domain, substitution with alanines could reduce the ability of the
protein to adapt to a changing lipid environment, thus excluding it
from membrane rafts. Substitution of the W23 with a longer, more
hydrophobic leucine resulted in a proteinwhichwas still found in the
DRMs. As this protein wasmore similar towild-type Vpu in efﬁciency
of CD4 down-modulation than W23A (data not shown), this further
suggests that structural changes are involved in raft inclusion and
exclusion of Vpu.
To demonstrate that membrane raft association was relevant to
Vpu functions and to virus replication, we assayed the various Vpu TM
mutants for the ability to down-modulate CD4 surface expression and
enhance virus release. Our results showed that all of the Vpu TM
mutants down-modulated CD4 surface expression although Vphu-
W22A was slightly impaired compared to the other mutants. We
measured enhanced virus release by two methods, release of p27
antigen from cells and by quantifying levels of infectious virus
released from cells. The two assays were in agreement and indicate
that virus release was signiﬁcantly reduced by the LVV11-13AAA,
IVV19-21AAA andW22Amutants with theW22A consistently having
the most reduction in particle release. Of these three mutants, both
IVV19-21AAA and W22A were not incorporated into rafts, implying a
correlation between membrane raft association and Vpu-mediated
virus release. One question that arises is, “Why did LVV11-13AAA
have impaired release since it was clearly observed in rafts?” While
the answer is presently unknown, it is possible that substitution of
three hydrophobic residues with less hydrophobic alanines may have
altered the structure/ﬂexibility of the protein or protein–protein
interactions (such as with BST-2) of the domain although it had no
effect on CD4 down-modulation. As is a caveat of all mutagenesis
based studies, it is unknown whether the results observed in this
study were based on structural alterations of the protein or roles for
speciﬁc amino acids. Further studies will be needed to determine the
affects the mutations introduced in this study have on the overall
protein structure as well as any protein–protein interactions.
However, regardless of the mechanisms by which the membrane
raft association and enhanced virion release function of the Vpu
proteins were altered these results demonstrate the ability of
exogenous forces to disrupt function. This introduces the potential
for therapeutic molecules designed to alter the spatial orientation of
the TMD such that membrane raft association and/or protein–protein
interactions (such as BST-2) would be disrupted.
Recently, Vpu was shown to antagonize the activity of a molecule
known as bone marrow stromal cell antigen 2 (BST-2) or tetherin
(Neil et al., 2008; Van Damme et al., 2008). BST-2 is thought to work
by “tethering” particles at the cell surface, which may account for the
observed maturation of HIV-1Δvpu (adherence of particles to the cell
plasma membrane with a common observation of several virus
particles in the “string of pearls” arrangement and the observation of
virus particles being taken or maturing into vesicles). BST-2 has been
shown to associate with membrane rafts, including the sites of HIV-1
maturation and release (Kupzig et al., 2003; Perez-Caballero et al.,
2009; Rollason et al., 2007). In the absence of Vpu, BST-2 may become
associated with rafts that are ultimately involved in virus assembly
and release from cells. This is supported by ﬁndings that HIV-1 Gag
and BST-2 co-localize in intracellular compartments of the cell (Neil
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virions suggesting that Vpu may associate with membrane rafts that
are not involved in virus assembly and release. It is known that
membrane rafts are diverse in both lipid and protein composition and
it has been shown that distinct rafts can be isolated using immune
selection procedures (Drevot et al., 2002; Knorr et al., 2009). One
group of investigators showed that wild-type BST-2 was found in
several different clusters on the plasma membrane and that removal
of the GPI anchor resulted in a BST-2 exclusively associated with sites
of budding (Perez-Caballero et al., 2009). This implies that wild-type
BST-2 is found in more than one type of membrane raft. Thus, it is
conceivable that Vpu could possibly interact with BST-2 before or after
transport to the Golgi complex and become associated with a
subpopulation of membrane rafts not associated with virus assembly
and release at the cell surface. Membrane rafts were originally shown
to initially form in the Golgi complex (Simons and van Meer, 1988)
and to be enriched in the trans Golgi network. However, more recent
studies have shown that the ER and cis Golgi are also sites for sorting
of proteins and lipids (Alfalah et al., 2005; Browman et al., 2006). BST-
2 was found in membrane rafts only after its N-linked carbohydrate
chains were fully processed, suggesting that raft association of this
protein occurs in the Golgi complex (Kupzig et al., 2003). Recent data
has been presented that suggests the presence of Vpu in the trans
Golgi is important for Vpu antagonism of BST-2 (Dubé et al., 2009). It
will be of interest to determine if Vpu and BST-2 can be co-
immunoprecipitated from similar rafts and if so, where does this
association occur? Finally, identiﬁcation of Vpu mutants that are
functional for either CD4 down-modulation or enhanced virus release
will be useful in determining if one function is more important for
pathogenesis using the SHIV/macaque model.
Materials and methods
Cells, viruses, and plasmids
The 293 and HeLa cell lines were maintained in Dulbecco's minimal
essential medium supplemented with 10% fetal bovine serum,
gentamicin (5 μg per ml) and penicillin/streptomycin (100 U per ml
and 100 μg per ml). TZM-bl cells expressing luciferase and β-ga-
lactosidase genes under the control of an HIV-1 promoter were
maintained in DMEM containing 10% fetal bovine serum with
antibiotics. HeLa CD4+ cells were maintained in DMEM containing
10% fetal bovine serum antibiotics and 1 mg/ml of G-418. The
derivation and pathogenicity of SHIVKU-1bMC33 and novpuSHIVKU-
1bMC33 have been described (McCormick-Davis et al., 2000; Singh et
al., 2003; Stephens et al., 2002). The derivation of the SHIVKU-2MC4Δvpu
plasmid has been described (Ruiz et al., 2010). Vectors expressing the
subtype B (pcvpuegfp) and C Vpu (pcvpuscegfp1) proteins fused to
enhanced green ﬂuorescent protein (eGFP) and the VpuTMEGFP
(pcvpuTMegfp) mutant have been previously described (Singh et al.,
2003; Gomez et al., 2005; Pacyniak et al., 2005; Ruiz et al., 2008). The
vector expressing the codon-optimized (human) Vpu protein (Vphu)
was kindly provided by the NIH AIDS Reference and Reagents Program
(Nguyen et al., 2004). The YFP-GPI and NFP-GPI constructs were kindly
provided by Dr. Akira Ono. The YFP-GPI construct has the ER
translocation signal from rabbit phlorizin hydrolase fused to the N-
terminus of Venus YFP and a GPI anchor sequence from CD59 fused to
the C-terminus. The non-ﬂuorescent version (NFP-YFP) contains the
mutation Y67C that abolishes ﬂuorophore formation. The vectors
expressing ER-DsRed2, Golgi-Red2, and Mem-DsRed2 were obtained
from Clontech.
Isolation of detergent-resistant membranes (DRMs)
293 cells were cultured in 60 mmdishes for 24 h, then transfected
using branched polyethylenimine (PEI; Sigma). At 48 h post-transfection, cells were lysed in ice cold DRM buffer (25 mM Tris
pH 7.5, 150 mMNaCl, 10 mMEDTA) containing 1% Triton X-100. Cells
remained on ice in lysis buffer for 20 min before being pushed
through a 22 ga needle at least 7 times. The lysate was then mixed
with an equal volume of 80% sucrose (w/v) in DRM buffer to a ﬁnal
concentration of 40% sucrose. The lysatewas placed in the bottomof a
SW41 ultracentrifuge tube and overlaid with 8 ml 30% sucrose and
2 ml 5% sucrose. Gradients were spun to equilibrium at 38,000rpm
(247,000×g) for 18 h (SW41 rotor, Beckman Coulter). One milliliter
fractions were taken from the top, concentrated, and analyzed by
Western blot using a rabbit anti-EGFP antibody or rabbit anti-Vpu
antibody (NIH AIDS Research and Reference Reagents Program).
Controls include the raft protein ﬂotillin-1 (mouse anti-ﬂotillin-1, BD
Biosciences) and the non-raft protein, transferrin receptor (mouse
anti-transferrin receptor, BD Biosciences). All experiments were
performed at least twice, and at most three times. Blots shown are
representative of all experiments.
For isolation of DRMs from virus-infected cells, C8166 cells were
inoculatedwith104TCID50of either SHIVKU-1bMC33 ornovpuSHIVKU-1bMC33
for 4 h. At this time, cells were washed twice and incubated in fresh
medium for 5 days at 37 °C. Cultures were starved and radiolabeled
with 1 mCi of 35S-methionine/cysteine for 2 h. The cells were
centrifuged at low speed (800×g) to pellet the cells, washed three
times in medium without serum and processed as above. One
milliliter fractions were taken from the top and raft (fractions 1–3),
middle (fractions 6–7), and non-raft (fractions 10–12) fractionswere
analyzed by immunoprecipitation using a rabbit anti-Vpu antibody
and by Western blot for raft and non-raft control proteins.
Isolation of detergent-resistant membranes (DRMs) at physiological
temperature
For these experiments, we used the procedure of Chen et al.
(2009). 293 cells were cultured in 12 well dishes for 24 h and then
transfected using PEI. At 36–48 h post-transfection, cells were lysed in
DRM37 (10 mM HEPES pH 7.0, 50 mM KOAc, 1 mMMg(OAc)2, 1 mM
EDTA, 200 mM sucrose). The lysates were pushed through a 22 ga
needle at least 7 times, then incubated at 37 °C for 5 min. Lysates were
then mixed with an equal volume of 2% Triton X-100 in DRM37 and
incubated at 37 °C for 5 min. The lysates were mixed with an equal
volume of 80% sucrose in DRM37, layered at the bottom of an
ultracentrifuge tube and overlaid with 7 ml 30% sucrose/DRM37 and
2 ml DRM37 (6.5% sucrose). Gradients were spun to equilibrium at
38,000 rpm overnight (SW41 rotor, Beckman Coulter) at 4 °C. One
milliliter fractions were taken from the top and analyzed for various
proteins by Western blot. All experiments were performed at least
twice, and at most three times. Blots shown are representative of all
experiments. Appropriate controls for raft isolation and purity were
performed and are shown.
Cholesterol depletion experiments
293 cells were transfected with a plasmid expressing VpuEGFP or
VpuSCEGFP1 and treated with 4 μM lovastatin for 48 h. Thirty minutes
prior to lysis of cells, the cultures were incubated with M-β-
cyclodextrin (M-β-CD; 10 mg/ml). Lysates were prepared, and
subjected to ultracentrifugation as described above. One milliliter
fractions were collected from the top of the gradient. Fractions 1–3, 6–
7, and 10–12 were each pooled, methanol precipitated and resus-
pended in 1× sample reducing buffer. The samples were then
analyzed for the presence of VpuEGFP or VpuSCEGFP1 by Western
blot using an antibody directed against EGFP. All experiments were
performed at least twice, and at most three times. Blots shown are
representative of all experiments. Appropriate controls for raft
isolation and purity were performed and are shown.
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293 cells cultured on cover slips were transfected with YFP-GPI or
NFP-GPI and VpuSCEGFP1 using PEI. At 48 h post-transfection, cover
slips were washed three times in 1× PBS, then incubated in primary
antibody (mouse anti-GFP, Clontech) for 30 min at 37 °C. Unbound
antibody was removed by washing three times in 1× PBS followed by
reaction with a secondary antibody (goat anti-mouse-Cy5, Molecular
Probes) at 37 °C for 30 min. Unbound antibody was removed by
washing three times in 1× PBS and cells ﬁxed in 2% paraformalde-
hyde/PBS for 15 min. Cover slips were mounted in SlowFade Antifade
solution A (Molecular Probes). A Nikon A1 confocal microscope was
used to collect 100× images with a 2× digital zoom, using EZ-C1
software. The pinhole was set to large (100 nm) for all wavelengths.
EGFP was excited using an argon 488 nm laser and viewed through
the FITC ﬁlter (525/25 nm) and Cy5 was excited at 638 nm and
viewed through a Cy5 ﬁlter (700/38 nm).Site-directed mutagenesis
Mutations introduced into all plasmids were accomplished using a
QuikChange site-directed mutagenesis kit (Stratagene) according to
the manufacturer's protocol. All plasmid inserts were sequenced to
ensure the validity of the mutations and that no other mutations were
introduced during the cloning process.Pulse–chase analysis of Vphu TMD mutant proteins
293 cells were transfected with vectors expressing each mutant
protein. At 48 h post-transfection, the mediumwas removed and cells
were incubated inmethionine/cysteine-freemedium for 2 h. The cells
were then radiolabeled with 200 μCi of 35S-Translabel (methionine
and cysteine, MP Biomedical) for 1 h. The radiolabel was chased in
DMEM containing 100× unlabeledmethionine/cysteinemedium for 0
and 6 h. Vphu proteins were immunoprecipitated using a rabbit anti-
Vpu serum and collected on Protein A-Sepharose beads on a rotator
for 18 h. Non-transfected 293 cells, starved, radiolabeled and chased
for 0 h served as a negative control. Beads were washed three times
with 1× radioimmunoprecipitation buffer (RIPA: 50 mM Tris–HCl, pH
7.5; 50 mMNaCl; 0.5% deoxycholate; 0.2% SDS; 10 mMEDTA), and the
samples resuspended in sample reducing buffer. Samples were boiled
and the Vphu proteins separated by SDS-PAGE (12% gel). Proteins
were then visualized using standard autoradiographic techniques. All
conditions were run in duplicate, the pixel densities of each band
determined using ImageJ software, normalized to the hour 0 sample,
and the average percent protein remaining and standard deviation
calculated.Confocal microscopy studies
293 cells were cultured on coverslips one day prior to being
transiently transfected with plasmids expressing either VpuEGFP or
VpuEGFPW23A and one of the intracellular marker proteins (ER-
DsRed2, Golgi-DsRed2 or Membrane-DsRed2) using branched poly-
ethylenimine (Sigma). Cultures were maintained for 36–48 h before
being washed three times in PBS, and ﬁxed in 2% paraformaldehyde/
PBS. Cover slips weremounted in glycerol containingmountingmedia
(Slowfade Antifade solution A). A Nikon A1 confocal microscope was
used to collect 100× images with a 2× digital zoom, using EZ-C1
software. The pinhole was set to large (100 nm) for all wavelengths.
EGFP was excited using an argon 488 nm laser and viewed through
the FITC ﬁlter (525/25 nm). DsRed2 were excited using a 561 DPSS
laser and viewed through the Texas Red ﬁlter (595/50 nm).Virion release assays
Hela cells (105) were seeded into each well of a 24-well tissue
culture plate 24 h prior to transfection. Cells were transfected as
described above with 1 μg of plasmid expressing full length SHIV
proviral DNA (either SHIVKU-2MC4 or SHIVΔVpu) and 200 ng of plasmid
expressing various mutant vphu genes. Cells were incubated at 37 °C
in 5% CO2 atmosphere for 48 h. Supernatants were collected and
cellular debris removed through low speed centrifugation. Cells were
lysed in 250 μl of 1× RIPA buffer and the nuclei removed through high
speed centrifugation. The amount of p27 present within the
supernatant and the cell lysates was determined using a commer-
cially available p27 ELISA kit (Zeptometrix Incorporated) and the
percent of p27 release calculated. All conditionswere run at least four
separate times and the average percent p27 release and standard
error calculated. Signiﬁcance with respect to the unmodiﬁed Vphu
was calculated using a Student's t-test with a pb0.01 considered
signiﬁcant.
Infectious virus release assays
TZM-bl cells (104) expressing luciferase and β-galactosidase genes
under the control of an HIV-1 promoter were seeded into each well of
a 96-well tissue culture plate 24 h prior to infection. Supernatants
collected from HeLa cells co-transfected with SHIV and Vphu
expressing plasmids as described above were added to the TZM-bl
cells and serially diluted. At 48 h post-infection, cells were washed
twice in 1× PBS and incubated in a ﬁxative solution (0.25%
glutaraldehyde, 0.8% formaldehyde in phosphate buffered saline) for
5 min at room temperature. The cells were washed three times in 1×
PBS and covered in staining solution (400 μg/ml X-gal, 4 mM MgCl2,
4 mM K3Fe(CN)6, 4 mM K4Fe(CN)6–3H2O in phosphate buffered
saline) and incubated for 2 h at 37 °C. Cells were washed once in 1×
PBS and then covered in 1× PBS during counting. The TCID50 for each
supernatant was calculated based onwells containing cells expressing
β-galactosidase. All conditions were run at least four times and the
TCID50 calculated. The average TCID50 and standard error were
calculated. Signiﬁcance in the restriction of infectivity was deter-
mined with respect to the unmodiﬁed Vphu using a Student's t-test
with pb0.01 considered signiﬁcant.
Assessment of CD4 cell surface expression
For analysis of cell surface CD4 expression in the presence of the
various Vphumutant proteins, HeLa CD4+ cellswere seeded into 6-well
tissue culture plates 1 day prior to transfection such that 24 h later they
would be 60–70% conﬂuent. Cells were co-transfected with plasmids
expressing one of the various Vphu mutant proteins and EGFP. Cells
transfected with EGFP only were used as the control. At 48 h post-
transfection, cells were removed from the plate using Ca2+/Mg2+-free
PBS containing 10 mM EDTA and stained with PE-Cy5 conjugated anti-
CD4 (BD Bioscience). Cells were analyzed using an LSRII ﬂow cytometer
and the mean ﬂuorescence intensity (MFI) of PE-Cy5 for transfected
cells (EGFP positive) and non-transfected (EGFP negative) was
calculated. An MFI ratio was calculated for each sample with the EGFP
control (no Vphu) normalized to 1.0. Normalized ratios from three
separate experiments were averaged and the standard error calculated.
All groups were compared to the EGFP control as well as the Vphu only
control using a Student's t-test (unpaired, pb0.01 signiﬁcant).
Acknowledgments
The work reported here is supported by NIH grant AI51981 and
AI091586 to E.B.S. We thank members of the KUMC Biotechnology
Support Facility and Northwestern University for their assistance with
the sequence analysis and oligonucleotide synthesis. The following
101A. Ruiz et al. / Virology 408 (2010) 89–102reagents were obtained through the AIDS Research and Reference
Reagent Program, Division of AIDS, NIAID, NIH: anti-Bst-2 (cat#
11722) fromDrs. Klaus Strebel and Amy Andrew; and TZM-bl fromDr.
John C. Kappes, Dr. Xiaoyun Wu and Tranzyme Inc.; the pcDNAVphu
(catalog #10076) from Drs. Stephen Bour and Klaus Strebel; the
HeLaCD4+ cells (catalog # 154) from Dr. Richard Axel. We thank the
laboratory of Dr. Akira Ono at the University of Michigan for the YFP-
GPI (originally by Kai Simons, Max Planck Institute of Molecular Cell
Biology and Genetics, Germany) and NFP-GPI constructed by Ian
Hogue in Dr. Ono's laboratory.References
Alfalah, M., Wetzel, G., Fischer, I., Busche, R., Sterchi, E.E., Zimmer, K.P., Sallmann, H.P.,
Naim, H.Y., 2005. A novel type of detergent-resistant membranes may contribute to
an early protein sorting event in epithelial cells. J. Biol. Chem. 280, 42636–42643.
Aloia, R.C., Tian, H., Jensen, F.C., 1993. Lipid composition and ﬂuidity of the human
immunodeﬁciency virus envelope and host cell plasma membranes. Proc. Natl.
Acad. Sci. USA 90, 5181–5185.
Barman, S., Nayak, D.P., 2000. Analysis of the transmembrane domain of inﬂuenza virus
neuraminidase, a type II transmembrane glycoprotein, for apical sorting and raft
association. J. Virol. 74, 6538–6545.
Bavari, S., Bosio, C.M., Wiegand, E., Ruthel, G., Will, A.B., Geisbert, T.W., Hevey, M.,
Schmaljohn, C., Schmaljohn, A., Aman, M.J., 2002. Lipid raft microdomains: a
gateway for compartmentalized trafﬁcking of Ebola and Marburg viruses. J. Exp.
Med. 195, 593–602.
Bender, F.C., Whitbeck, J.C., Ponce de Leon, M., Lou, H., Eisenberg, R.J., Cohen, G.H., 2003.
Speciﬁc association of glycoprotein B with lipid rafts during herpes simplex virus
entry. J. Virol. 77, 9542–9552.
Bhattacharya, J., Peters, P.J., Clapham, P.R., 2004. Human immunodeﬁciency virus type 1
envelope glycoproteins that lack cytoplasmic domain cysteines: impact on
association with membrane lipid rafts and incorporation onto budding virus
particles. J. Virol. 78, 5500–5506.
Bhattacharya, J., Repik, A., Clapham, P.R., 2006. Gag regulates association of human
immunodeﬁciency virus type 1 envelope with detergent-resistant membranes. J.
Virol. 80, 5292–5300.
Browman, D.T., Resek, M.E., Zajchowski, L.D., Robbins, S.M., 2006. Erlin-1 and erlin-2 are
novel members of the prohibitin family of proteins that deﬁne lipid-raft-like
domains of the ER. J. Cell Sci. 119, 3149–3160.
Brown, E.L., Lyles, D.S., 2003. Organization of the vesicular stomatitis virus glycoprotein
into membrane microdomains occurs independently of intracellular viral compo-
nents. J. Virol. 77, 3985–3992.
Brugger, B., Glass, B., Haberkant, P., Leibrecht, I., Wieland, F.T., Krausslich, H.-G., 2005.
The HIV lipidome: a raft with an unusual composition. Proc. Natl. Acad. Sci. USA
103, 2641–2646.
Candler, A., Featherstone, M., Ali, R., Maloney, L., Watts, A., Fischer, W.B., 2005.
Computational analysis of mutations in the transmembrane region of Vpu from
HIV-1. Biochim. Biophys. Acta 1716, 1–10.
Chan, W.E., Lin, H.H., Chen, S.S., 2005. Wild-type-like viral replication potential of
human immunodeﬁciency virus type 1 envelope mutants lacking palmitoylation
signals. J. Virol. 79, 8374–8387.
Chen, X., Jen, A., Warley, A., Lawrence, M.J., Quinn, P.J., Morris, R.J., 2009. Isolation at
physiological temperature of detergent-resistant membranes with properties
expected of lipid rafts: the inﬂuence of buffer composition. Biochem. J. 417,
525–533.
Chung, C.S., Huang, C.Y., Chang, W., 2005. Vaccinia virus penetration requires
cholesterol and results in speciﬁc viral envelope proteins associated with lipid
rafts. J. Virol. 79, 1623–1634.
Douglas, J.L., Viswanathan, K., McCarroll, M.N., Gustin, J.K., Früh, K., Moses, A.V., 2009.
Vpu directs the degradation of the human immunodeﬁciency virus restriction
factor BST-2/Tetherin via a β-TrCP-dependent mechanism. J. Virol. 83, 7931–7947.
Drevot, P., Langlet, C., Guo, X.J., Bernard, A.M., Colard, O., Chauvin, J.P., Lasserre, R., He, H.
T., 2002. TCR signal initiation machinery is pre-assembled and activated in a subset
of membrane rafts. EMBO J. 21, 1899–1908.
Dubé, M., Roy, B.B., Guiot-Guillain, P., Mercier, J., Binette, J., Leung, G., Cohen, E.A., 2009.
Suppression of Tetherin-restricting activity upon human immunodeﬁciency virus
type 1 particle release correlates with localization of Vpu in the trans-Golgi
network. J. Virol. 83, 4574–4590.
Epand, R.F., Thomas, A., Brasseur, R., Vishwanathan, S.A., Hunter, E., Epand, R.M., 2006.
Juxtamembrane protein segments that contribute to recruitment of cholesterol
into domains. Biochemistry 45, 6105–6114.
Fujita, K., Omura, S., Silver, J., 1997. Rapid degradation of CD4 in cells expressing human
immunodeﬁciency virus type 1 Env and Vpu is blocked by proteasome inhibitors. J.
Gen. Virol. 78, 619–625.
Gkantiragas, I., Brügger, B., Stüven, E., Kaloyanova, D., Li, X.Y., Löhr, K., Lottspeich, F.,
Wieland, F.T., Helms, J.B., 2001. Sphingomyelin-enrichedmicrodomains at the Golgi
complex. Mol. Biol. Cell 12, 1819–1833.
Gomez, L.M., Pacyniak, E., Mulcahy, E.R., Flick, M., Gomez, M., Nerrient, E., Ayouda, A.,
Santiago, M., Hahn, B., Stephens, E.B., 2005. Vpu mediated CD4 down-regulation
and degradation is conserved among highly divergent SIVcpz strains. Virology 335,
46–60.Hout, D.R., Gomez, M., Pacyniak, E., Gomez, L., Mulchay, E.R., Culley, N., Pinson, D.M.,
Powers, M., Wong, S.W., Stephens, E.B., 2005. Scrambling of the amino acids within
the transmembrane domain of Vpu results in simian-human immunodeﬁciency
virus (SHIVTM) that is less pathogenic for pig-tailed macaques. Virology 339, 56–69.
Keller, P., Simons, K., 1998. Cholesterol is required for surface transport of inﬂuenza
virus hemagglutinin. J. Cell Biol. 140, 1357–1367.
Klimkait, T., Strebel, K., Hoggan, M.D., Martin, M.A., Orenstein, J.M., 1990. The human
immunodeﬁciency virus type 1-speciﬁc protein Vpu is required for efﬁcient virus
maturation and release. J. Virol. 64, 621–629.
Knorr, R., Karacsonyi, C., Lindner, R.J., 2009. Endocytosis of MHC molecules by distinct
membrane rafts. Cell Sci. 122, 1584–1594.
Kruger, J., Fischer, W.B., 2008. Exploring the conformational space of Vpu from HIV-1: a
versatile adaptable protein. J. Comput. Chem. 29, 2416–2424.
Kupzig, S., Korolchuk, V., Rollason, R., Sugden, A., Wilde, A., Banting, G., 2003. Bst-2/
HM1.24 is a raft-associated apical membrane protein with an unusual topology.
Trafﬁc 4, 694–709.
Kusumi, A., Suzuki, K., 2005. Toward understanding the dynamics of membrane-raft-
based molecular interactions. Biochim. Biophys. Acta 1746, 234–251.
Li, M., Yang, C., Tong, S., Weidmann, A., Compans, R.W., 2002. Palmitoylation of the
murine leukemia virus envelope protein is critical for lipid raft association and
surface expression. J. Virol. 76, 11845–11852.
Manié, S.N., de Breyne, S., Vincent, S., Gerlier, D., 2000. Measles virus structural
components are enriched intolipid raft microdomains: a potential cellular location
for virus assembly. J. Virol. 74, 305–311.
Marty, A., Meanger, J., Mills, J., Shields, B., Ghildyal, R., 2004. Association of matrix
protein of respiratory syncytial virus with the host cell membrane of infected cells.
Arch. Virol. 149, 199–210.
McCormick-Davis, C., Mukherjee, S., Dalton, S.B., Singh, D.K., Pinson, D.M., Berman, N.E.J.,
Foresman, L., Stephens, E.B., 2000. A molecular clone of simian–human immunode-
ﬁciency virus (SHIVKU-1bMC33) with a truncated, non-membrane bound Vpu results is
not required for rapid CD4+T cell loss andneuroAIDS inpig-tailedmacaques. Virology
272, 112–126.
Medigeshi, G.R., Hirsch, A.J., Streblow, D.N., Nikolich-Zugich, J., Nelson, J.A., 2008. West
Nile virus entry requires cholesterol-rich membrane microdomains and is
independent of alphavbeta3 integrin. J. Virol. 82, 5212–5219.
Neil, S.J., Zang, T., Bieniasz, P.D., 2008. Tetherin inhibits retrovirus release and is
antagonized by HIV-1 Vpu. Nature 451, 425–430.
Nguyen, D.H., Hildreth, J.E., 2000. Evidence for budding of human immunodeﬁciency
virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74,
3264–3272.
Nguyen, K.-L., Llano, M., Akari, H., Miyagi, E., Poeschla, E.M., Strebel, K., Bour, S., 2004.
Codon optimization of the HIV-1 vpu and vif genes stabilizes their messenger RNA
and allows for highly efﬁcient Rev-independent expression. Virology 319, 163–175.
Ono, A., Freed, E.O., 2001. Plasma membrane rafts play a critical role in HIV-1 assembly
and release. Proc. Natl. Acad. Sci. USA 98, 13925–13930.
Pacyniak, E., Gomez, M., Gomez, L., Mulcahy, E., Jackson, M., Flick, M., Hout, D.R.,
Stephens, E.B., 2005. Identiﬁcation of a region within the cytoplasmic domain of the
subtype B Vpu protein of human immunodeﬁciency virus type 1 (HIV-1) that
responsible for retention in the Golgi complex and its absence in subtype C Vpu
proteins. AIDS Res. Hum. Retro. 21, 379–394.
Patil, A., Gautam, A., Bhattacharya, J., 2010. Evidence that Gag facilitates HIV-1 envelope
association both in GPI-enriched plasma membrane and detergent resistant
membranes and facilitates envelope incorporation onto virions in primary CD4+
T cells. Virol. J. 7, 3.
Perez-Caballero, D., Zang, T., Ebrahimi, A., McNatt, M.W., Gregory, D.A., Johnson, M.C.,
Bieniasz, P.D., 2009. Tetherin inhibits HIV-1 release by directly tethering virions to
cells. Cell 139, 499–511.
Pralle, A., Keller, P., Florin, E.L., Simons, K., Horber, J.K., 2000. Sphingolipid–cholesterol
rafts diffuse as small entities in the plasma membrane of mammalian cells. J. Cell
Biol. 148, 997–1008.
Prior, I.A., Muncke, C., Parton, R.G., Hancock, J.F., 2003. Direct visualization of Ras
proteins in spatially distinct cell surface microdomains. J. Cell Biol. 160, 165–170.
Rollason, R., Korolchuk, V., Hamilton, C., Schu, P., Banting, G., 2007. Clathrin-mediated
endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine
motif. J. Cell Sci. 120, 3850–3858.
Rouso, I., Mixon, M.B., Chen, B.K., Kim, P.S., 2000. Palmitoylation of the HIV-1 envelope
glycoprotein is critical for viral infectivity. Proc. Natl. Acad. Sci. USA 97,
13523–13525.
Ruiz, A., Hill, M.S., Schmitt, K., Guatelli, J., Stephens, E.B., 2008. Requirements of
membrane proximal tyrosine and dileucine sorting signals for efﬁcient transport of
the subtype C Vpu proteins to the plasma membrane and virus release. Virology
378, 58–68.
Ruiz, A., Guatelli, J.C., Stephens, E.B., 2010. The Vpu protein: new concepts in virus
release and CD4 down-modulation. Curr. HIV-1 Res. 8, 240–252.
Scheiffele, P., Rietveld, A., Wilk, T., Simons, K., 1999. Inﬂuenza viruses select ordered
lipid domains during budding from the plasma membrane. J. Biol. Chem. 274,
2038–2044.
Schubert, U., Bour, S., Ferrer-Montiel, A.V., Montal, M., Maldarell, F., Strebel, K., 1996.
The two biological activities of human immunodeﬁciency virus type 1 Vpu protein
involve two separable structural domains. J. Virol. 70, 809–819.
Schubert, U., Anton, L.C., Bacik, I., Cox, J.H., Bour, S., Bennink, J.R., Orlowski, M., Strebel,
K., Yewdell, J.W., 1998. CD4 glycoprotein degradation induced by human
immunodeﬁciency virus type 1 Vpu protein requires the function of proteasomes
and the ubiquitin-conjugating pathway. J. Virol. 72, 2280–2288.
Schuck, S., Honsho, M., Ekroos, K., Shevchenko, A., Simons, K., 2003. Resistance of cell
membranes to different detergents. Proc. Natl. Acad. Sci. USA 100, 5795–5800.
102 A. Ruiz et al. / Virology 408 (2010) 89–102Sharma, P., Varma, R., Sarasij, R.C., Ira, Gousset, K., Krishnamoorthy, G., Rao, M., Mayor,
S., 2004. Nanoscale organization of multiple GPI-anchored proteins in living cell
membranes. Cell 116, 577–589.
Shogomori, H., Brown, D.A., 2003. Use of detergents to study membrane rafts: the good,
the bad, and the ugly. J. Biol. Chem. 384, 1259–1263.
Simons, K., van Meer, G., 1988. Lipid sorting in epithelial cells. Biochemistry 27,
6197–6202.
Singh, D.K., Grifﬁn, D.M., Pacyniak, E., Jackson, M., Werle, M., Wisdom, B., Sun, F., Hout,
D.R., Pinson, D.M., Gunderson, R.S., Powers, M.F., Wong, S.W., Stephens, E.B., 2003.
The presence of the casein kinase II phosphorylation sites of Vpu enhances the CD4
+ T cell loss caused by a simian human immunodeﬁciency virus (SHIVKU-1bMC33) in
pig-tailed macaques. Virology 313, 435–451.
Sramala, I., Lemaitre, V., Faraldo-Gomez, J.D., Vincent, S., Watts, A., Fischer, W.B., 2003.
Molecular dynamics simulations on the ﬁrst two helices of Vpu from HIV-1.
Biophys. J. 84, 3276–3284.Stephens, E.B., McCormick, C., Pacyniak, E., Grifﬁn, D., Sun, F., Pinson, D.M., Gunderson,
R.S., Wong, S.W., Berman, N.E.J., Singh, D.K., 2002. A chimeric simian–human
immunodeﬁciency virus with the vpu sequences removed prior to envelope
glycoprotein gene (novpuSHIVKU1bMC33) results in enhanced Env biosynthesis in
lymphocytes but is less pathogenic in pig-tailed macaques. Virology 293,
252–261.
Strebel, K., Klimkait, T., Martin, M.A., 1988. A novel gene of HIV-1, vpu, and its 16-
kilodalton product. Science 241, 1221–1223.
Van Damme, N., Goff, D., Katsura, C., Jorgenson, R.L., Mitchell, R., Johnson, M.C.,
Stephens, E.B., Guatelli, J.C., 2008. The interferon-induced protein BST-2 restricts
HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.
Cell Host Microbe 3, 245–252.
Vishwanathan, S.A., Thomas, A., Brasseur, R., Epand, R.F., Hunter, E., Epand, R.M., 2008.
Hydrophobic substitutions in the ﬁrst residue of the CRAC segment of the gp41
protein of HIV. Biochemistry 47, 124–130.
